Operating Income - Cuu Long Pharmaceutical JSC (VN:DCL) - Alpha Spread
C

Cuu Long Pharmaceutical JSC
VN:DCL

Watchlist Manager
Cuu Long Pharmaceutical JSC
VN:DCL
Watchlist
Price: 25 650 VND -0.39%
Market Cap: 1.9T VND
Have any thoughts about
Cuu Long Pharmaceutical JSC?
Write Note

Cuu Long Pharmaceutical JSC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cuu Long Pharmaceutical JSC
Operating Income Peer Comparison

Comparables:
H
DHT
I
IMP
D
DMC
D
DHG
T
TRA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Cuu Long Pharmaceutical JSC
VN:DCL
Operating Income
â‚«70.7B
CAGR 3-Years
15%
CAGR 5-Years
43%
CAGR 10-Years
N/A
H
HaTay Pharmaceutical JSC
VN:DHT
Operating Income
â‚«75.1B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
5%
I
Imexpharm Corp
VN:IMP
Operating Income
â‚«329.9B
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
14%
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Operating Income
â‚«206.1B
CAGR 3-Years
8%
CAGR 5-Years
-17%
CAGR 10-Years
3%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Operating Income
â‚«824B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
3%
T
Traphaco JSC
VN:TRA
Operating Income
â‚«305.8B
CAGR 3-Years
-18%
CAGR 5-Years
-4%
CAGR 10-Years
4%

See Also

What is Cuu Long Pharmaceutical JSC's Operating Income?
Operating Income
70.7B VND

Based on the financial report for Dec 31, 2023, Cuu Long Pharmaceutical JSC's Operating Income amounts to 70.7B VND.

What is Cuu Long Pharmaceutical JSC's Operating Income growth rate?
Operating Income CAGR 5Y
43%

Over the last year, the Operating Income growth was -45%. The average annual Operating Income growth rates for Cuu Long Pharmaceutical JSC have been 15% over the past three years , 43% over the past five years .

Back to Top